BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 24746014)

  • 1. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
    Rosenholm JM; Sahlgren C; Lindén M
    Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous carbon nanomaterials in drug delivery and biomedical application.
    Zhao Q; Lin Y; Han N; Li X; Geng H; Wang X; Cui Y; Wang S
    Drug Deliv; 2017; 24(sup1):94-107. PubMed ID: 29124979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
    Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
    Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Mesoporous Silica Nanocarriers in Oncology.
    Baeza A; Vallet-Regi M
    Curr Drug Targets; 2018 Feb; 19(3):213-224. PubMed ID: 27262488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer.
    Castillo RR; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Feb; 14(2):229-243. PubMed ID: 27402029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
    Cong VT; Gaus K; Tilley RD; Gooding JJ
    Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
    Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
    J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.